Modeling combination chemo‐immunotherapy for heterogeneous tumors
Abstract Hypermutable cancers create opportunities for the development of various immunotherapies, such as immune checkpoint blockade (ICB) therapy. However, emergent studies have revealed that many hypermutated tumors have poor prognosis due to heterogeneous tumor antigen landscapes, yet the underl...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2025-09-01
|
| シリーズ: | Quantitative Biology |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/qub2.98 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|